Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Microbix Biosystems Inc T.MBX

Alternate Symbol(s):  MBXBF

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.


TSX:MBX - Post by User

Comment by RazeKreationson Jan 15, 2022 2:18pm
160 Views
Post# 34320541

RE:RRSP Season

RE:RRSP Season Yes some would be selling for tax purposes. Especially if  it is within a rrsp.  Most are not going to sell at this ridiculously  low share price.  Volumes  are way too low for any traction for gains at this point. Simply Wall Street has MBX 42% undervalued. Should currently be $1.25 fair value.  At some point there will be coverage and strong buy recommendations  from wealth managers.
Then there should be more awareness  that will translate into more trading volumes to get the snowball rolling down the hill. I think it is going to be quiet until first quarter is released mid February.  Only having one analyst (Chelsea Stellick from Industrial  Alliance) that is recognized  at this point doesn't  help either. Too many good things happening to give up now. I predict a minimum  of 200% gains this year. Probably  much higher if everything  falls into place with long term contracts.          
IMO
<< Previous
Bullboard Posts
Next >>